The Scotts Miracle-Gro Company (SMG) SEC Filings & Earnings Calls
EquiReason read 22 The Scotts Miracle-Gro Company SEC filings in the last 12 months. Latest: 8-K on 2026-10-16 — Separation agreement with Christopher Hagedorn, indicating departure of a key officer. No financial details or performance impact stated..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 3.5B
- P/E TTM
- 50.2
- Dividend yield
- 4.5%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
16 Oct 20268-K · 5.02Separation agreement with Christopher Hagedorn, indicating departure of a key officer. No financial details or performance impact stated.open
Risks flagged
Key executive departure could lead to operational disruption or strategic shifts.
“Separation agreement with Christopher Hagedorn”
15 Sep 20268-K · 1.02, 8.01Scotts Miracle-Gro terminated a material definitive agreement; no details on counterparty or financial impact provided.open
Risks flagged
Loss of a material agreement may impact revenue or operations; lack of disclosure increases uncertainty.
“Termination of material definitive agreement; no specifics on counterparty, terms, or financial effect.”
5 Aug 202610-QScotts Miracle-Gro reported Q3 net sales up 1.1% but net income from continuing operations down 33% due to higher impairment charges and lower gross margin.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Consolidated · Q3-2026 | $1.17B | +1% y/y |
| Net sales · Consolidated · 9M-2026 | $2.99B | +2% y/y |
| Gross margin rate · Consolidated · Q3-2026 | 31.2% | |
| Gross margin rate · Consolidated · 9M-2026 | 35.7% | |
| Net income from continuing operations · Consolidated · Q3-2026 | $104M | -33% y/y |
| Net income from continuing operations · Consolidated · 9M-2026 | $319M | +3% y/y |
| U.S. Consumer segment net sales · U.S. Consumer · Q3-2026 | $1.03B | +0% y/y |
| U.S. Consumer segment net sales · U.S. Consumer · 9M-2026 | $2.74B | +2% y/y |
| Other segment net sales · Other · Q3-2026 | $139M | +8% y/y |
| Other segment net sales · Other · 9M-2026 | $248M | +6% y/y |
Risks flagged
Restructuring and impairment charges
“Total impairment, restructuring and other charges, net $ 48.2 $ 1.0 $ 53.5 $ 34.5” · word for word
Hawthorne divestiture loss
“For the nine months ended June 27, 2026, we recorded a loss of $101.8 related to the sale of the Hawthorne business in North America.” · word for word
Macroeconomic and tariff uncertainty
“We continue to monitor the impacts of macroeconomic conditions, including elevated interest rates and inflationary pressures on input costs and consumer behavior, as well as geopolitical uncertainty, including the duration and resolution of ongoing conflicts, potential escalation of tensions and global supply chain disruptions, and ongoing changes to global ” · word for word
29 Jul 20268-K · 2.02Net sales $1.17B (+1% y/y); GAAP gross margin rate 31.2; Non-GAAP adjusted gross margin rate 31.3; Guidance: Non-GAAP adjusted EPS guidance raised from $4.15-$4.35 to $4.30-$4.45earningsopen
Figures in the filing · each found in the filing text
| Net sales · U.S. Consumer · Q3-2026 | $1.17B | +1% y/y |
| GAAP gross margin rate · Q3-2026 | 31.2% | |
| Non-GAAP adjusted gross margin rate · Q3-2026 | 31.3% | |
| GAAP net income from continuing operations per diluted share · Q3-2026 | $1.75 | -34% y/y |
| Non-GAAP adjusted net income from continuing operations per diluted share · Q3-2026 | $2.82 | +8% y/y |
| Net leverage ratio · Q3-2026 | $3.78 | |
| Free cash flow guidance · FY2026 | $275M |
Guidance
Non-GAAP adjusted EPS guidance raised from $4.15-$4.35 to $4.30-$4.45
EPS guidance raised due to margin management and balance sheet strength; demand stable with low single-digit growth; capex investment in automation and AI.
Risks flagged
Higher freight and commodity costs due to Iran conflict pressuring gross margin.
“driven by higher freight and commodity costs resulting from the Iran conflict.” · word for word
1 Jul 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
CEO departure may create uncertainty, but succession plan suggests orderly transition.
“Long-term succession plan executed; Baxter has been COO since 2024.”
6 May 202610-QNet Sales $1.46B (+5% y/y); Gross Margin Rate 41.8; Net Income from Continuing Operations $263M (+19% y/y)open
Figures in the filing · each found in the filing text
| Net Sales · Consolidated · Q2-2026 | $1.46B | +5% y/y |
| Gross Margin Rate · Consolidated · Q2-2026 | 41.8% | |
| Net Income from Continuing Operations · Consolidated · Q2-2026 | $263M | +19% y/y |
| U.S. Consumer Net Sales · U.S. Consumer · Q2-2026 | $1.38B | +5% y/y |
| U.S. Consumer Segment Profit · U.S. Consumer · Q2-2026 | $437M | +12% y/y |
| Interest Expense · Consolidated · Q2-2026 | $31M | -15% y/y |
| Diluted EPS from Continuing Operations · Consolidated · Q2-2026 | $4.46 | +18% y/y |
| Operating Cash Flow · Consolidated · H1-2026 | $-150M | +42% y/y |
| Leverage Ratio · Consolidated · Q2-2026 | $3.71 | |
| Interest Coverage Ratio · Consolidated · Q2-2026 | $5.62 |
Risks flagged
Tariff and Trade Policy Risk
“We continue to monitor the impacts of macroeconomic conditions, including elevated interest rates and inflationary pressures on input costs and consumer behavior, as well as geopolitical uncertainty, including the duration and resolution of ongoing conflicts, potential escalation of tensions and global supply chain disruptions, and ongoing changes to global ” · word for word
Seasonal Concentration Risk
“Due to the seasonal nature of the consumer lawn and garden business, significant portions of our U.S. Consumer and Other segment net sales ship to our retail customers during our second and third fiscal quarters.” · word for word
29 Apr 20268-K · 2.02, 7.01Net sales $1.46B (+5% y/y); Gross margin 41.8; Adjusted EBITDA $437M (+9% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net sales · Consolidated · Q2-2026 | $1.46B | +5% y/y |
| Gross margin · Consolidated · Q2-2026 | 41.8% | |
| Adjusted EBITDA · Consolidated · Q2-2026 | $437M | +9% y/y |
| Net income from continuing operations · Consolidated · Q2-2026 | $263M | +19% y/y |
| Adjusted diluted net income per common share from continuing operations · Consolidated · Q2-2026 | $4.53 | +13% y/y |
Risks flagged
Discontinued operations loss of $24.7M in Q2 and $102.0M YTD may indicate ongoing restructuring costs
“Loss from discontinued operations, net of tax ($24.7M) Q2, ($102.0M) YTD” · word for word
9 Apr 20268-K · 8.01Sale of Hawthorne business to Vireo Growth Inc. for 213M Vireo shares and warrants for 80M additional shares; Hawthorne classified as discontinued operation.being acquiredopen
Risks flagged
Consideration in Vireo shares introduces valuation and liquidity risk; warrants could dilute.
“sold the Company’s Hawthorne business to Vireo for 213 million subordinate voting shares and warrants to acquire 80 million additional Vireo Shares.”
20 Feb 20268-K · 2.02Net sales (revised FY2025) $3.26B; Net income from continuing operations (revised FY2025) $182Mearningsopen
Figures in the filing · each found in the filing text
| Net sales (revised FY2025) · FY2025 | $3.26B | |
| Net income from continuing operations (revised FY2025) · FY2025 | $182M |
4 Feb 202610-QQ1 FY2026 net sales declined 3.3% YoY, gross margin improved 90 bps, operating loss narrowed 52.4%, and Hawthorne business classified as held for sale with a $104.8M impairment.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Consolidated · Q1-2026 | $354M | -3% y/y |
| Gross Margin Rate · Consolidated · Q1-2026 | 25.0% | |
| Net Loss from Continuing Operations · Consolidated · Q1-2026 | $-48M | |
| Interest Expense · Consolidated · Q1-2026 | $27M | -20% y/y |
| Leverage Ratio · Consolidated · Q1-2026 | $4.03 | |
| U.S. Consumer Net Sales · U.S. Consumer · Q1-2026 | $329M | -4% y/y |
| U.S. Consumer Segment Profit · U.S. Consumer · Q1-2026 | $9M | -8% y/y |
| Operating Cash Flow · Consolidated · Q1-2026 | $-370M | |
| Capital Expenditures · Consolidated · Q1-2026 | $20M | -32% y/y |
Risks flagged
Hawthorne Discontinued Operations Valuation Risk
“During the three months ended December 27, 2025, we recorded a non-cash pre-tax charge of $104.8 related to a valuation adjustment to recognize the carrying amount of the Hawthorne business at fair value less estimated costs to sell.” · word for word
Seasonal Working Capital and Debt Dependency
“Cash used in operating activities totaled $370.4 for the three months ended December 27, 2025... driven by the timing of inventory production and lower payments to customers related to promotional programs.” · word for word
29 Jan 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen
Risks flagged
Potential dilution from increased share authorization for incentive plan.
“increase the maximum number of common shares available for grant to participants under the Plan by 2,750,000 Common Shares.” · word for word
28 Jan 20268-K · 2.02U.S. Consumer net sales $328M; GAAP gross margin rate 25; Non-GAAP adjusted gross margin rate 25.4; Guidance: Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%earningsopen
Figures in the filing · each found in the filing text
| U.S. Consumer net sales · U.S. Consumer · Q1-2026 | $329M | |
| GAAP gross margin rate · Q1-2026 | 25.0% | |
| Non-GAAP adjusted gross margin rate · Q1-2026 | 25.4% | |
| GAAP net loss from continuing operations per share · Q1-2026 | $-0.83 | |
| Non-GAAP adjusted net loss from continuing operations per share · Q1-2026 | $-0.77 | |
| Non-GAAP adjusted EBITDA · Q1-2026 | $3M | |
| Net leverage ratio · Q1-2026 | $4.03 | |
| Share repurchase program authorization | $500M |
Guidance
Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%
Guidance reaffirmed; divestiture and share repurchase announced; Q1 results in line.
Risks flagged
Hawthorne divestiture consideration in Vireo shares introduces valuation risk.
“Vireo will acquire Hawthorne in exchange for an investment in Vireo” · word for word
17 Dec 2025DEF 14AProxy statement seeking shareholder approval for amendment and restatement of Long-Term Incentive Plan, including 2.75M new share authorization, and disclosing insider ownership structure.open
Figures in the filing · each found in the filing text
| Common Shares Outstanding · 2025-12-01 | 58,007,149 | |
| Potential Fully Diluted Overhang · 2025-12-01 | 12.3% | |
| Hagedorn Partnership Ownership · 2025-12-01 | 22.8% |
Risks flagged
Equity Dilution from Share Authorization
“The share authorization after adding the 2,750,000 new Common Shares represents, on a pro forma basis, approximately 12.32% of fully diluted Common Shares of the Company.” · word for word
Governance Risk from Concentrated Ownership
“James Hagedorn ... 23.98%; Katherine Hagedorn Littlefield ... 22.80%; Nathan E. Baxter ... 22.83%”
25 Nov 202510-KNet Sales $3.41B (-4% y/y); Net Income (Loss) $145M; Gross Margin Rate 30.6; Guidance: FY2026 capex guided ~$100M; no revenue or margin guidance providedopen
Figures in the filing · each found in the filing text
| Net Sales · Consolidated · FY2025 | $3.41B | -4% y/y |
| Net Income (Loss) · Consolidated · FY2025 | $145M | |
| Gross Margin Rate · Consolidated · FY2025 | 30.6% | |
| U.S. Consumer Net Sales · U.S. Consumer · FY2025 | $2.99B | -1% y/y |
| Hawthorne Net Sales · Hawthorne · FY2025 | $166M | -44% y/y |
| U.S. Consumer Segment Profit · U.S. Consumer · FY2025 | $573M | +15% y/y |
| Hawthorne Segment Profit (Loss) · Hawthorne · FY2025 | $3M | |
| Operating Cash Flow · Consolidated · FY2025 | $371M | -44% y/y |
| Capital Expenditures · Consolidated · FY2025 | $97M | +16% y/y |
| Leverage Ratio · Consolidated · Q4-2025 | $4.10 |
Guidance
FY2026 capex guided ~$100M; no revenue or margin guidance provided
Only capex guidance provided; no revenue or margin outlook. Management tone is neutral with focus on cost savings and innovation.
Risks flagged
Cannabis Oversupply Persistence
“We expect that the oversupply of cannabis will continue to adversely impact our Hawthorne segment.” · word for word
Roundup Agreement Termination Risk
“In the event the Third Restated Agreement for Monsanto’s consumer Roundup products terminates or Monsanto’s consumer Roundup business materially declines, we would lose a substantial source of future earnings and overhead expense absorption.” · word for word
Securities Litigation
“The amended consolidated complaint was filed on May 9, 2025 on behalf of a proposed class of purchasers of Common Shares between May 5, 2021, and August 1, 2023, and asserts claims under Section 10(b), Rule 10b-5 and Section 20(a) of the Exchange Act against the Company and certain of its current and former officers based on alleged misstatements about the C” · word for word
Tariff Exposure
“We are also continuing to monitor ongoing changes to global trade policies, including the imposition of tariffs.” · word for word
24 Nov 20258-K · 1.01, 1.02, 2.03Revolving credit facility $1.50B; Term loan $500Mopen
Figures in the filing · each found in the filing text
| Revolving credit facility | $1.50B | |
| Term loan | $500M |
Risks flagged
Reduction in total facility size from $2.5B to $2.0B may indicate lower liquidity buffer, but also reflects deleveraging.
“The Sixth Amended and Restated Credit Agreement consisted of ... aggregate amount of $2.5 billion” · word for word
5 Nov 20258-K · 2.02U.S. Consumer net sales $2.99B; GAAP gross margin rate 30.6; Non-GAAP adjusted gross margin rate 31.2; Guidance: Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%earningsopen
Figures in the filing · each found in the filing text
| U.S. Consumer net sales · U.S. Consumer · FY2025 | $2.99B | |
| GAAP gross margin rate · FY2025 | 30.6% | |
| Non-GAAP adjusted gross margin rate · FY2025 | 31.2% | |
| GAAP earnings per share · FY2025 | $2.47 | |
| Non-GAAP adjusted earnings per share · FY2025 | $3.74 | |
| Non-GAAP adjusted EBITDA · FY2025 | $581M | |
| Free cash flow · FY2025 | $274M | |
| Net leverage ratio · FY2025 | $4.10 |
Guidance
Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%
FY2025 results beat expectations; FY2026 guidance reaffirms margin expansion and cash flow generation.
The Scotts Miracle-Gro Company — questions
- What did The Scotts Miracle-Gro Company file recently?
- 22 SEC filings in the last 12 months. Latest: 8-K on 2026-10-16 — Separation agreement with Christopher Hagedorn, indicating departure of a key officer. No financial details or performance impact stated.
Every figure on this page comes from The Scotts Miracle-Gro Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.